XML 32 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Accumulated other comprehensive loss
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accounting standard cumulative-effect adjustment   $ 0     $ 1,525   $ (1,525)
Beginning balance (in shares) at Dec. 31, 2017     41,098        
Beginning balance at Dec. 31, 2017 $ 554,847   $ 1 $ 561,650   $ (6,804)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 65,754     65,754      
Foreign currency translation adjustment (6,320)         (6,320)  
Purchases and retirement of common stock     (1,371)        
Purchases and retirement of common stock (34,818)     (34,818)      
Issuances under equity plans, including tax benefits (in shares)     299        
Issuances under equity plans, including tax benefits (1,900)     (1,900)      
Stock-based compensation (in shares)     28        
Stock-based compensation 13,876     13,876      
Ending balance (in shares) at Dec. 30, 2018     40,054        
Ending balance at Dec. 30, 2018 591,439   $ 1 606,087   (14,649)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 63,073     63,073      
Foreign currency translation adjustment 1,411         1,411  
Purchases and retirement of common stock     (1,855)        
Purchases and retirement of common stock (38,826)     (38,826)      
Issuances under equity plans, including tax benefits (in shares)     365        
Issuances under equity plans, including tax benefits (893)     (893)      
Stock-based compensation (in shares)     29        
Stock-based compensation $ 9,769     9,769      
Ending balance (in shares) at Dec. 29, 2019 38,593   38,593        
Ending balance at Dec. 29, 2019 $ 625,973   $ 1 639,210   (13,238)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accounting standard cumulative-effect adjustment 639,210 $ (602)     $ (602)    
Net income (loss) (141,841)     (141,841)      
Foreign currency translation adjustment (1,590)         (1,590)  
Purchases and retirement of common stock     (3,557)        
Purchases and retirement of common stock (52,346)     (52,346)      
Issuances under equity plans, including tax benefits (in shares)     429        
Issuances under equity plans, including tax benefits (1,517)     (1,517)      
Stock-based compensation (in shares)     28        
Stock-based compensation $ 9,113     9,113      
Ending balance (in shares) at Dec. 27, 2020 35,493   35,493        
Ending balance at Dec. 27, 2020 $ 437,190   $ 1 $ 452,017   $ (14,828)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Change in accounting standard cumulative-effect adjustment $ 452,017